CC
AMED

Corton Capital’s Amedisys AMED Stock Holding History

Corton Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,261
Closed -$211K – 568
2023
Q3 		$211K Sell
2,261
-1,169
-34% -$108K 0.11% 299
2023
Q2 		$314K Buy
+3,430
New +$281K 0.15% 200
2022
Q2 		– Sell
-1,269
Closed -$219K – 331
2022
Q1 		$219K Buy
+1,269
New +$190K 0.09% 337

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Corton Capital's AMED Position: Q4 2023 in Review

Corton Capital sold out of Amedisys (AMED) in Q4 2023, closing a stake of 2,261 shares — an estimated $211K sold.

Corton Capital first reported a position in AMED in Q1 2022 and held it in 3 quarters. The position peaked at $314K in Q2 2023. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

  • Corton Capital reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
  • Corton Capital sold 2,261 Amedisys shares in Q4 2023, an estimated $211K.
  • Corton Capital first reported a position in Amedisys in Q1 2022 and held it in 3 quarters.
  • Corton Capital's Amedisys position peaked at $314K in Q2 2023.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Corton Capital's 13F filing for Q4 2023, filed 14 Feb 2024.